Net profit of Indrayani Biotech rose 258.33% to Rs 3.87 crore in the quarter ended March 2024 as against Rs 1.08 crore during the previous quarter ended March 2023. Sales declined 9.89% to Rs 44.38 crore in the quarter ended March 2024 as against Rs 49.25 crore during the previous quarter ended March 2023.
For the full year,net profit declined 27.23% to Rs 6.36 crore in the year ended March 2024 as against Rs 8.74 crore during the previous year ended March 2023. Sales rose 2.03% to Rs 166.23 crore in the year ended March 2024 as against Rs 162.93 crore during the previous year ended March 2023.
| Particulars | Quarter Ended | Year Ended |
| | Mar. 2024 | Mar. 2023 | % Var. | Mar. 2024 | Mar. 2023 | % Var. |
| Sales | 44.38 | 49.25 | -10 | 166.23 | 162.93 | 2 |
| OPM % | 22.94 | 6.44 | - | 14.11 | 10.26 | - |
| PBDT | 5.69 | 3.00 | 90 | 14.78 | 15.65 | -6 |
| PBT | 4.73 | 1.85 | 156 | 10.97 | 12.31 | -11 |
| NP | 3.87 | 1.08 | 258 | 6.36 | 8.74 | -27 |